nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—melanoma—rectum cancer	0.468	0.518	CtDrD
Docetaxel—stomach cancer—rectum cancer	0.435	0.482	CtDrD
Docetaxel—KIF11—mammalian vulva—rectum cancer	0.00273	0.041	CbGeAlD
Docetaxel—KIF11—female reproductive system—rectum cancer	0.00234	0.0351	CbGeAlD
Docetaxel—KIF11—vagina—rectum cancer	0.00212	0.0318	CbGeAlD
Docetaxel—KIF11—lymph node—rectum cancer	0.00137	0.0205	CbGeAlD
Docetaxel—MAP4—renal system—rectum cancer	0.00135	0.0202	CbGeAlD
Docetaxel—BCL2—epithelium—rectum cancer	0.00132	0.0198	CbGeAlD
Docetaxel—MAP2—seminal vesicle—rectum cancer	0.00132	0.0198	CbGeAlD
Docetaxel—BCL2—smooth muscle tissue—rectum cancer	0.00127	0.0191	CbGeAlD
Docetaxel—BCL2—renal system—rectum cancer	0.00122	0.0184	CbGeAlD
Docetaxel—EGFR—mammalian vulva—rectum cancer	0.00113	0.017	CbGeAlD
Docetaxel—MAP4—female reproductive system—rectum cancer	0.00108	0.0162	CbGeAlD
Docetaxel—MAP2—urethra—rectum cancer	0.00104	0.0156	CbGeAlD
Docetaxel—MAP2—mammalian vulva—rectum cancer	0.000992	0.0149	CbGeAlD
Docetaxel—TUBB2B—seminal vesicle—rectum cancer	0.000983	0.0148	CbGeAlD
Docetaxel—BCL2—female reproductive system—rectum cancer	0.000981	0.0147	CbGeAlD
Docetaxel—MAP4—vagina—rectum cancer	0.000976	0.0146	CbGeAlD
Docetaxel—TUBB—seminal vesicle—rectum cancer	0.00093	0.014	CbGeAlD
Docetaxel—TUBB2A—seminal vesicle—rectum cancer	0.000925	0.0139	CbGeAlD
Docetaxel—SLC22A7—renal system—rectum cancer	0.000917	0.0138	CbGeAlD
Docetaxel—TUBB6—seminal vesicle—rectum cancer	0.000913	0.0137	CbGeAlD
Docetaxel—SLCO1B3—vagina—rectum cancer	0.000854	0.0128	CbGeAlD
Docetaxel—MAP2—female reproductive system—rectum cancer	0.000849	0.0127	CbGeAlD
Docetaxel—TUBB4A—renal system—rectum cancer	0.00082	0.0123	CbGeAlD
Docetaxel—MAPT—lymph node—rectum cancer	0.000803	0.012	CbGeAlD
Docetaxel—ABCC10—seminal vesicle—rectum cancer	0.000799	0.012	CbGeAlD
Docetaxel—TUBB4B—seminal vesicle—rectum cancer	0.000793	0.0119	CbGeAlD
Docetaxel—TUBB6—epithelium—rectum cancer	0.000793	0.0119	CbGeAlD
Docetaxel—TUBB2B—renal system—rectum cancer	0.000792	0.0119	CbGeAlD
Docetaxel—TUBB—smooth muscle tissue—rectum cancer	0.000779	0.0117	CbGeAlD
Docetaxel—TUBB2B—urethra—rectum cancer	0.000778	0.0117	CbGeAlD
Docetaxel—TUBB2A—smooth muscle tissue—rectum cancer	0.000775	0.0116	CbGeAlD
Docetaxel—MAP2—vagina—rectum cancer	0.000768	0.0115	CbGeAlD
Docetaxel—TUBB6—smooth muscle tissue—rectum cancer	0.000764	0.0115	CbGeAlD
Docetaxel—TUBB2B—mammalian vulva—rectum cancer	0.000741	0.0111	CbGeAlD
Docetaxel—TUBB—urethra—rectum cancer	0.000736	0.0111	CbGeAlD
Docetaxel—TUBB6—renal system—rectum cancer	0.000736	0.011	CbGeAlD
Docetaxel—TUBB2A—urethra—rectum cancer	0.000733	0.011	CbGeAlD
Docetaxel—TUBB6—urethra—rectum cancer	0.000723	0.0108	CbGeAlD
Docetaxel—TUBB—mammalian vulva—rectum cancer	0.000701	0.0105	CbGeAlD
Docetaxel—TUBB2A—mammalian vulva—rectum cancer	0.000697	0.0105	CbGeAlD
Docetaxel—TUBB6—mammalian vulva—rectum cancer	0.000688	0.0103	CbGeAlD
Docetaxel—TUBB4B—smooth muscle tissue—rectum cancer	0.000664	0.00997	CbGeAlD
Docetaxel—TUBB4A—female reproductive system—rectum cancer	0.000656	0.00985	CbGeAlD
Docetaxel—ABCC10—renal system—rectum cancer	0.000644	0.00967	CbGeAlD
Docetaxel—TUBB4B—renal system—rectum cancer	0.000639	0.0096	CbGeAlD
Docetaxel—TUBB2B—female reproductive system—rectum cancer	0.000635	0.00952	CbGeAlD
Docetaxel—ABCC10—urethra—rectum cancer	0.000633	0.00949	CbGeAlD
Docetaxel—MAP4—lymph node—rectum cancer	0.000631	0.00947	CbGeAlD
Docetaxel—TUBB4B—urethra—rectum cancer	0.000628	0.00943	CbGeAlD
Docetaxel—ABCC10—mammalian vulva—rectum cancer	0.000602	0.00904	CbGeAlD
Docetaxel—TUBB4B—mammalian vulva—rectum cancer	0.000598	0.00897	CbGeAlD
Docetaxel—TUBB2A—female reproductive system—rectum cancer	0.000597	0.00896	CbGeAlD
Docetaxel—TUBB6—female reproductive system—rectum cancer	0.000589	0.00884	CbGeAlD
Docetaxel—TUBB2B—vagina—rectum cancer	0.000574	0.00861	CbGeAlD
Docetaxel—BCL2—lymph node—rectum cancer	0.000574	0.00861	CbGeAlD
Docetaxel—EGFR—lymph node—rectum cancer	0.000567	0.00851	CbGeAlD
Docetaxel—ABCC1—seminal vesicle—rectum cancer	0.000565	0.00848	CbGeAlD
Docetaxel—TUBB—vagina—rectum cancer	0.000543	0.00815	CbGeAlD
Docetaxel—TUBB2A—vagina—rectum cancer	0.00054	0.00811	CbGeAlD
Docetaxel—TUBB6—vagina—rectum cancer	0.000533	0.008	CbGeAlD
Docetaxel—CYP1B1—smooth muscle tissue—rectum cancer	0.000526	0.0079	CbGeAlD
Docetaxel—ABCC2—renal system—rectum cancer	0.000517	0.00776	CbGeAlD
Docetaxel—ABCC10—female reproductive system—rectum cancer	0.000516	0.00774	CbGeAlD
Docetaxel—TUBB4B—female reproductive system—rectum cancer	0.000512	0.00769	CbGeAlD
Docetaxel—CYP1B1—renal system—rectum cancer	0.000506	0.0076	CbGeAlD
Docetaxel—MAP2—lymph node—rectum cancer	0.000497	0.00746	CbGeAlD
Docetaxel—ABCG2—seminal vesicle—rectum cancer	0.000468	0.00702	CbGeAlD
Docetaxel—ABCC10—vagina—rectum cancer	0.000466	0.007	CbGeAlD
Docetaxel—TUBB4B—vagina—rectum cancer	0.000463	0.00695	CbGeAlD
Docetaxel—ABCC1—urethra—rectum cancer	0.000447	0.00672	CbGeAlD
Docetaxel—ABCC1—mammalian vulva—rectum cancer	0.000426	0.00639	CbGeAlD
Docetaxel—ABCC2—female reproductive system—rectum cancer	0.000414	0.00622	CbGeAlD
Docetaxel—CYP1B1—female reproductive system—rectum cancer	0.000406	0.00609	CbGeAlD
Docetaxel—TUBB4A—lymph node—rectum cancer	0.000384	0.00576	CbGeAlD
Docetaxel—TUBB2B—lymph node—rectum cancer	0.000371	0.00557	CbGeAlD
Docetaxel—ABCG2—urethra—rectum cancer	0.00037	0.00556	CbGeAlD
Docetaxel—ABCG2—mammalian vulva—rectum cancer	0.000353	0.00529	CbGeAlD
Docetaxel—TUBB—lymph node—rectum cancer	0.000351	0.00527	CbGeAlD
Docetaxel—CYP3A5—renal system—rectum cancer	0.00035	0.00525	CbGeAlD
Docetaxel—TUBB2A—lymph node—rectum cancer	0.000349	0.00524	CbGeAlD
Docetaxel—TUBB6—lymph node—rectum cancer	0.000345	0.00517	CbGeAlD
Docetaxel—ABCC1—vagina—rectum cancer	0.00033	0.00495	CbGeAlD
Docetaxel—ABCC10—lymph node—rectum cancer	0.000302	0.00453	CbGeAlD
Docetaxel—TUBB4B—lymph node—rectum cancer	0.0003	0.0045	CbGeAlD
Docetaxel—ABCG2—vagina—rectum cancer	0.000273	0.0041	CbGeAlD
Docetaxel—CYP3A4—renal system—rectum cancer	0.000263	0.00394	CbGeAlD
Docetaxel—CYP3A5—vagina—rectum cancer	0.000254	0.00381	CbGeAlD
Docetaxel—ABCC2—lymph node—rectum cancer	0.000242	0.00364	CbGeAlD
Docetaxel—CYP1B1—lymph node—rectum cancer	0.000237	0.00356	CbGeAlD
Docetaxel—ABCB1—seminal vesicle—rectum cancer	0.000231	0.00346	CbGeAlD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000216	0.00702	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—ITGA2—rectum cancer	0.000215	0.00698	CbGpPWpGaD
Docetaxel—ABCC1—lymph node—rectum cancer	0.000213	0.0032	CbGeAlD
Docetaxel—MAPT—Copper homeostasis—TP53—rectum cancer	0.000212	0.00688	CbGpPWpGaD
Docetaxel—CYP3A4—female reproductive system—rectum cancer	0.00021	0.00316	CbGeAlD
Docetaxel—EGFR—GRB2 events in EGFR signaling—NRAS—rectum cancer	0.000208	0.00676	CbGpPWpGaD
Docetaxel—ABCB1—epithelium—rectum cancer	0.0002	0.00301	CbGeAlD
Docetaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—rectum cancer	0.0002	0.00652	CbGpPWpGaD
Docetaxel—EGFR—SHC1 events in EGFR signaling—NRAS—rectum cancer	0.0002	0.00651	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000197	0.00642	CbGpPWpGaD
Docetaxel—EGFR—Signaling by constitutively active EGFR—KRAS—rectum cancer	0.000194	0.0063	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000188	0.00611	CbGpPWpGaD
Docetaxel—ABCB1—renal system—rectum cancer	0.000186	0.00279	CbGeAlD
Docetaxel—BCL2—EPO signaling pathway—HRAS—rectum cancer	0.000183	0.00597	CbGpPWpGaD
Docetaxel—MAPT—Kit receptor signaling pathway—HRAS—rectum cancer	0.000183	0.00595	CbGpPWpGaD
Docetaxel—ABCB1—urethra—rectum cancer	0.000183	0.00274	CbGeAlD
Docetaxel—BCL2—IL-5 Signaling Pathway—KRAS—rectum cancer	0.000181	0.00588	CbGpPWpGaD
Docetaxel—EGFR—GRB2 events in EGFR signaling—KRAS—rectum cancer	0.000179	0.00582	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000178	0.0058	CbGpPWpGaD
Docetaxel—ABCG2—lymph node—rectum cancer	0.000177	0.00265	CbGeAlD
Docetaxel—SLC22A7—Fluoropyrimidine Activity—TP53—rectum cancer	0.000175	0.00569	CbGpPWpGaD
Docetaxel—ABCB1—mammalian vulva—rectum cancer	0.000174	0.00261	CbGeAlD
Docetaxel—EGFR—SHC1 events in EGFR signaling—KRAS—rectum cancer	0.000172	0.0056	CbGpPWpGaD
Docetaxel—MAPT—LPA receptor mediated events—HRAS—rectum cancer	0.000171	0.00558	CbGpPWpGaD
Docetaxel—BCL2—Intrinsic Pathway for Apoptosis—TP53—rectum cancer	0.000167	0.00544	CbGpPWpGaD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—rectum cancer	0.000167	0.00544	CbGpPWpGaD
Docetaxel—BCL2—IL2-mediated signaling events—NRAS—rectum cancer	0.000165	0.00537	CbGpPWpGaD
Docetaxel—EGFR—Nanoparticle-mediated activation of receptor signaling—NRAS—rectum cancer	0.000165	0.00537	CbGpPWpGaD
Docetaxel—EGFR—Signaling by constitutively active EGFR—HRAS—rectum cancer	0.000165	0.00536	CbGpPWpGaD
Docetaxel—EGFR—GRB2 events in ERBB2 signaling—NRAS—rectum cancer	0.000156	0.00508	CbGpPWpGaD
Docetaxel—EGFR—Extracellular vesicle-mediated signaling in recipient cells—NRAS—rectum cancer	0.000156	0.00508	CbGpPWpGaD
Docetaxel—EGFR—GRB2 events in EGFR signaling—HRAS—rectum cancer	0.000152	0.00494	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—TP53—rectum cancer	0.000151	0.00493	CbGpPWpGaD
Docetaxel—ABCB1—female reproductive system—rectum cancer	0.000149	0.00224	CbGeAlD
Docetaxel—BCL2—Integrated Cancer Pathway—TP53—rectum cancer	0.000149	0.00484	CbGpPWpGaD
Docetaxel—EGFR—SHC1 events in ERBB2 signaling—NRAS—rectum cancer	0.000148	0.00482	CbGpPWpGaD
Docetaxel—BCL2—IL-2 Signaling Pathway—HRAS—rectum cancer	0.000148	0.0048	CbGpPWpGaD
Docetaxel—EGFR—SHC1 events in EGFR signaling—HRAS—rectum cancer	0.000146	0.00476	CbGpPWpGaD
Docetaxel—BCL2—Interleukin-11 Signaling Pathway—HRAS—rectum cancer	0.000142	0.00463	CbGpPWpGaD
Docetaxel—BCL2—IL2-mediated signaling events—KRAS—rectum cancer	0.000142	0.00462	CbGpPWpGaD
Docetaxel—EGFR—Nanoparticle-mediated activation of receptor signaling—KRAS—rectum cancer	0.000142	0.00462	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.000138	0.00451	CbGpPWpGaD
Docetaxel—ABCB1—vagina—rectum cancer	0.000135	0.00202	CbGeAlD
Docetaxel—EGFR—Extracellular vesicle-mediated signaling in recipient cells—KRAS—rectum cancer	0.000134	0.00437	CbGpPWpGaD
Docetaxel—EGFR—GRB2 events in ERBB2 signaling—KRAS—rectum cancer	0.000134	0.00437	CbGpPWpGaD
Docetaxel—BCL2—IL-3 Signaling Pathway—HRAS—rectum cancer	0.00013	0.00425	CbGpPWpGaD
Docetaxel—EGFR—Internalization of ErbB1—NRAS—rectum cancer	0.000129	0.0042	CbGpPWpGaD
Docetaxel—EGFR—SHC1 events in ERBB2 signaling—KRAS—rectum cancer	0.000128	0.00415	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000127	0.00415	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—ITGA2—rectum cancer	0.000127	0.00413	CbGpPWpGaD
Docetaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—rectum cancer	0.000126	0.00411	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000126	0.0041	CbGpPWpGaD
Docetaxel—BCL2—IL2-mediated signaling events—HRAS—rectum cancer	0.000121	0.00393	CbGpPWpGaD
Docetaxel—EGFR—Nanoparticle-mediated activation of receptor signaling—HRAS—rectum cancer	0.000121	0.00393	CbGpPWpGaD
Docetaxel—EGFR—Gastric Cancer Network 2—TP53—rectum cancer	0.000116	0.00379	CbGpPWpGaD
Docetaxel—EGFR—Bladder Cancer—TP53—rectum cancer	0.000116	0.00379	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—NRAS—rectum cancer	0.000116	0.00377	CbGpPWpGaD
Docetaxel—EGFR—Extracellular vesicle-mediated signaling in recipient cells—HRAS—rectum cancer	0.000114	0.00372	CbGpPWpGaD
Docetaxel—EGFR—GRB2 events in ERBB2 signaling—HRAS—rectum cancer	0.000114	0.00372	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.000114	0.0037	CbGpPWpGaD
Docetaxel—BCL2—Kit receptor signaling pathway—HRAS—rectum cancer	0.000112	0.00366	CbGpPWpGaD
Docetaxel—EGFR—Bladder Cancer—HRAS—rectum cancer	0.000111	0.00362	CbGpPWpGaD
Docetaxel—EGFR—Internalization of ErbB1—KRAS—rectum cancer	0.000111	0.00362	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.000111	0.00361	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000111	0.00361	CbGpPWpGaD
Docetaxel—EGFR—SHC1 events in ERBB2 signaling—HRAS—rectum cancer	0.000108	0.00353	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—NRAS—rectum cancer	0.000108	0.00352	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—NRAS—rectum cancer	0.000105	0.00343	CbGpPWpGaD
Docetaxel—ABCG2—Fluoropyrimidine Activity—TP53—rectum cancer	0.000103	0.00336	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—KRAS—rectum cancer	9.97e-05	0.00325	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	9.79e-05	0.00319	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	9.54e-05	0.00311	CbGpPWpGaD
Docetaxel—EGFR—Internalization of ErbB1—HRAS—rectum cancer	9.45e-05	0.00308	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—NRAS—rectum cancer	9.41e-05	0.00306	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—KRAS—rectum cancer	9.31e-05	0.00303	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—NRAS—rectum cancer	9.21e-05	0.003	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—NRAS—rectum cancer	9.11e-05	0.00297	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—KRAS—rectum cancer	9.07e-05	0.00295	CbGpPWpGaD
Docetaxel—MAPT—BDNF signaling pathway—HRAS—rectum cancer	8.95e-05	0.00291	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—rectum cancer	8.86e-05	0.00288	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—TP53—rectum cancer	8.83e-05	0.00287	CbGpPWpGaD
Docetaxel—ABCB1—lymph node—rectum cancer	8.71e-05	0.00131	CbGeAlD
Docetaxel—TUBB—Cell Cycle, Mitotic—TYMS—rectum cancer	8.69e-05	0.00283	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—HRAS—rectum cancer	8.48e-05	0.00276	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	8.4e-05	0.00274	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—KRAS—rectum cancer	8.39e-05	0.00273	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	8.32e-05	0.00271	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—TP53—rectum cancer	8.31e-05	0.00271	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TP53—rectum cancer	8.28e-05	0.00269	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ITGA2—rectum cancer	8.28e-05	0.00269	CbGpPWpGaD
Docetaxel—EGFR—a6b1 and a6b4 Integrin signaling—HRAS—rectum cancer	8.26e-05	0.00269	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NRAS—rectum cancer	8.21e-05	0.00267	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	8.19e-05	0.00266	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	8.11e-05	0.00264	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—KRAS—rectum cancer	8.09e-05	0.00263	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—TP53—rectum cancer	8.06e-05	0.00262	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—KRAS—rectum cancer	7.93e-05	0.00258	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—KRAS—rectum cancer	7.84e-05	0.00255	CbGpPWpGaD
Docetaxel—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—rectum cancer	7.84e-05	0.00255	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TYMS—rectum cancer	7.77e-05	0.00253	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—HRAS—rectum cancer	7.71e-05	0.00251	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	7.47e-05	0.00243	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—TP53—rectum cancer	7.46e-05	0.00243	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—TP53—rectum cancer	7.41e-05	0.00241	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—TYMS—rectum cancer	7.2e-05	0.00234	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—rectum cancer	7.19e-05	0.00234	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—HRAS—rectum cancer	7.13e-05	0.00232	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—HRAS—rectum cancer	7.09e-05	0.00231	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	7.06e-05	0.0023	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—NRAS—rectum cancer	6.98e-05	0.00227	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—HRAS—rectum cancer	6.88e-05	0.00224	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—HRAS—rectum cancer	6.74e-05	0.00219	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HRAS—rectum cancer	6.67e-05	0.00217	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—TYMS—rectum cancer	6.58e-05	0.00214	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TYMS—rectum cancer	6.44e-05	0.00209	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	6.28e-05	0.00204	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—KRAS—rectum cancer	6.24e-05	0.00203	CbGpPWpGaD
Docetaxel—EGFR—LPA receptor mediated events—HRAS—rectum cancer	6.23e-05	0.00203	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—KRAS—rectum cancer	6.01e-05	0.00196	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	6e-05	0.00195	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	5.99e-05	0.00195	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ITGA2—rectum cancer	5.91e-05	0.00192	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—TP53—rectum cancer	5.89e-05	0.00192	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TYMS—rectum cancer	5.89e-05	0.00192	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—NRAS—rectum cancer	5.73e-05	0.00186	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—TP53—rectum cancer	5.54e-05	0.0018	CbGpPWpGaD
Docetaxel—KIF11—Immune System—NRAS—rectum cancer	5.53e-05	0.0018	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—rectum cancer	5.43e-05	0.00177	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—TP53—rectum cancer	5.34e-05	0.00174	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	5.17e-05	0.00168	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—NRAS—rectum cancer	5.14e-05	0.00167	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—HRAS—rectum cancer	5.11e-05	0.00166	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—KRAS—rectum cancer	4.93e-05	0.0016	CbGpPWpGaD
Docetaxel—KIF11—Immune System—KRAS—rectum cancer	4.76e-05	0.00155	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	4.59e-05	0.0015	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—NRAS—rectum cancer	4.53e-05	0.00147	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—KRAS—rectum cancer	4.43e-05	0.00144	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—HRAS—rectum cancer	4.41e-05	0.00144	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—NRAS—rectum cancer	4.33e-05	0.00141	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—NRAS—rectum cancer	4.33e-05	0.00141	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—NRAS—rectum cancer	4.26e-05	0.00139	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—HRAS—rectum cancer	4.19e-05	0.00136	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	4.13e-05	0.00135	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—NRAS—rectum cancer	4.07e-05	0.00132	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—NRAS—rectum cancer	4.05e-05	0.00132	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HRAS—rectum cancer	4.04e-05	0.00132	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—NRAS—rectum cancer	4.03e-05	0.00131	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—NRAS—rectum cancer	4.01e-05	0.00131	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—rectum cancer	3.99e-05	0.0013	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	3.95e-05	0.00129	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—NRAS—rectum cancer	3.93e-05	0.00128	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—KRAS—rectum cancer	3.9e-05	0.00127	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—NRAS—rectum cancer	3.77e-05	0.00123	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	3.77e-05	0.00123	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—NRAS—rectum cancer	3.77e-05	0.00123	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HRAS—rectum cancer	3.76e-05	0.00122	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—NRAS—rectum cancer	3.74e-05	0.00122	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—KRAS—rectum cancer	3.73e-05	0.00121	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—KRAS—rectum cancer	3.73e-05	0.00121	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—NRAS—rectum cancer	3.71e-05	0.00121	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—NRAS—rectum cancer	3.69e-05	0.0012	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—KRAS—rectum cancer	3.69e-05	0.0012	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—KRAS—rectum cancer	3.67e-05	0.00119	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—KRAS—rectum cancer	3.5e-05	0.00114	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—NRAS—rectum cancer	3.49e-05	0.00114	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—KRAS—rectum cancer	3.49e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	3.49e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—rectum cancer	3.48e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—KRAS—rectum cancer	3.47e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—KRAS—rectum cancer	3.45e-05	0.00112	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	3.4e-05	0.00111	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—KRAS—rectum cancer	3.39e-05	0.0011	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	3.34e-05	0.00109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—HRAS—rectum cancer	3.31e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—rectum cancer	3.28e-05	0.00107	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—KRAS—rectum cancer	3.25e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—KRAS—rectum cancer	3.25e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	3.25e-05	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—rectum cancer	3.23e-05	0.00105	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—KRAS—rectum cancer	3.22e-05	0.00105	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—KRAS—rectum cancer	3.19e-05	0.00104	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—KRAS—rectum cancer	3.18e-05	0.00103	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—HRAS—rectum cancer	3.17e-05	0.00103	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—HRAS—rectum cancer	3.12e-05	0.00101	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	3.06e-05	0.000994	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NRAS—rectum cancer	3.04e-05	0.000989	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—rectum cancer	3.01e-05	0.000979	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—KRAS—rectum cancer	3.01e-05	0.000978	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—HRAS—rectum cancer	2.98e-05	0.000969	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	2.96e-05	0.000964	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—HRAS—rectum cancer	2.96e-05	0.000964	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—HRAS—rectum cancer	2.95e-05	0.00096	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HRAS—rectum cancer	2.93e-05	0.000955	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	2.89e-05	0.000941	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	2.88e-05	0.000936	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—rectum cancer	2.78e-05	0.000905	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	2.76e-05	0.000898	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—rectum cancer	2.76e-05	0.000898	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—rectum cancer	2.76e-05	0.000898	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—rectum cancer	2.74e-05	0.00089	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	2.72e-05	0.000884	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—rectum cancer	2.71e-05	0.000882	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—rectum cancer	2.7e-05	0.000879	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KRAS—rectum cancer	2.62e-05	0.000851	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—rectum cancer	2.61e-05	0.000849	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—rectum cancer	2.58e-05	0.000839	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NRAS—rectum cancer	2.57e-05	0.000837	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—rectum cancer	2.55e-05	0.000831	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NRAS—rectum cancer	2.48e-05	0.000807	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	2.44e-05	0.000796	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—rectum cancer	2.36e-05	0.000769	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—rectum cancer	2.33e-05	0.000757	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—rectum cancer	2.32e-05	0.000757	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—TYMS—rectum cancer	2.28e-05	0.000744	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—rectum cancer	2.22e-05	0.000724	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KRAS—rectum cancer	2.21e-05	0.00072	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—rectum cancer	2.13e-05	0.000695	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KRAS—rectum cancer	2.13e-05	0.000695	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KRAS—rectum cancer	2e-05	0.000652	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—rectum cancer	1.95e-05	0.000635	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—rectum cancer	1.88e-05	0.000612	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—rectum cancer	1.81e-05	0.00059	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—rectum cancer	1.7e-05	0.000554	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—rectum cancer	1.66e-05	0.00054	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TYMS—rectum cancer	1.62e-05	0.000526	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TYMS—rectum cancer	1.56e-05	0.000509	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	1.54e-05	0.000502	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—rectum cancer	1.47e-05	0.000477	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—rectum cancer	1.44e-05	0.00047	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—rectum cancer	1.43e-05	0.000465	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TYMS—rectum cancer	1.42e-05	0.000463	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TYMS—rectum cancer	1.41e-05	0.000459	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—rectum cancer	1.41e-05	0.000458	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	1.37e-05	0.000446	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—rectum cancer	1.26e-05	0.000411	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—rectum cancer	1.24e-05	0.000405	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—rectum cancer	1.21e-05	0.000395	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—rectum cancer	1.21e-05	0.000394	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—rectum cancer	1.07e-05	0.000349	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—rectum cancer	1.06e-05	0.000344	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—rectum cancer	1.03e-05	0.000335	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TYMS—rectum cancer	1.02e-05	0.000331	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—rectum cancer	9.34e-06	0.000304	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—rectum cancer	8.54e-06	0.000278	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—rectum cancer	8.36e-06	0.000272	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—rectum cancer	8.04e-06	0.000262	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—rectum cancer	7.88e-06	0.000257	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMS—rectum cancer	7.69e-06	0.00025	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—rectum cancer	7.35e-06	0.000239	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—rectum cancer	7.2e-06	0.000234	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—rectum cancer	6.84e-06	0.000223	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—rectum cancer	6.78e-06	0.000221	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—rectum cancer	6.25e-06	0.000203	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—rectum cancer	6.12e-06	0.000199	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—rectum cancer	5.77e-06	0.000188	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—rectum cancer	5.52e-06	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—rectum cancer	4.75e-06	0.000155	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMS—rectum cancer	4.73e-06	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—rectum cancer	4.22e-06	0.000137	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—rectum cancer	4.04e-06	0.000131	CbGpPWpGaD
